Avellino Lab USA

AVELLINO HITS THE 1-MILLION GENETIC TEST MILESTONE On track for over 10,000 gene-based diagnostic tests performed a day https://www.biospace.com//avellino-hits-the-1-million-gen/

It was an honor to have Tommy Pham join us for our AvaGen launch event on Saturday at AAO-2019. Tommy shared his journey with keratoconus and met with numerous doctors plus the whole Avellino team. Thank you again, Tommy, for joining us!

Register now for a special premiere screening, October 13, 2019, by Avellino Labs, a global leader in precision medicine. Join us as we proudly unveil our next-generation sequencing (NGS) genetic technology for the diagnosis of keratoconus and TGFBI corneal dystrophies. Presenters for this key event include Dr. Eric Donnenfeld MD; Edward J. Holland, MD; Terry Kim, MD; Richard L. Lindstrom, MD; and Elizabeth Yeu, MD. The event will debut at the Blue Shield of California Theate...r at the Yerba Buena Center for the Arts, across the street from the Moscone Center, from 5:30 pm to 7:30 pm. Be sure to register prior to the event to secure your spot: https://www.avellinopremiere.com/ #genetictesting #AAO2019 #genetics #Avellino #Avellinolabs #DNAisLife #precisionmedicine #keratoconus #cornealdystrophy #nextgenerationsequencing #YBCA #TerryKimMD #LizYeu #ophthalmology

Avellino is headed to San Francisco this October 12-15 for the annual AAO meeting. Make sure to stop by Avellino Booth 6670 to get a preview of our latest genetic diagnostic. The first of its kind for detecting the risk for #keratoconus and for the presence of #cornealdystrophies. At Avellino, we are working collaboratively with best-in-class partners to bring precision medicine into the modern #eyecare practice, by delivering actionable information delivered from an individual patient’s unique genes. Stop by Booth 6670 and say hello! Learn more about the AAO meeting at: https://bit.ly/2uPvMna #AAO2019 #precisionmedicine #booth6670 #genetictest #cornealdystrophy

For Dr. William Wiley, Avellino gene testing has become a useful tool in his clinical assessment of patients who present with potential signs of corneal dystrophy after refractive surgery. Hear him discuss how our technology helps clinicians and patients take an important step forward toward precise diagnosis and future gene therapies for the treatment of corneal dystrophy. Get Dr. Wiley's insights here: http://ow.ly/YrAc50uJepE... #genetictesting #precisionmedicine #cornea #LASIK

We are honored to announce that Avellino founder, chairman, and president Gene Lee has been awarded the 2019 Ellis Island Medal of Honor for his pioneering work in genetic diagnostic and therapeutic technologies. Mr. Lee has also been named to the World Economic Forum’s Precision Medicine Council. At Avellino, our work is singularly focused on advancing the application of genetic technologies to deliver on the promise of precision medicine for improved healthcare for improved healthcare outcomes for all. I’m proud to be honored to be recognized by two such respected organizations committed to the betterment of society, said Lee. Past medal recipients include seven U.S. presidents, world and business leaders, and Nobel Laureates. Learn more here: http://bit.ly/31RFTJG

We had a great time at the 2019 American Society of Cataract and Refractive Surgery Conference with Drs. William Wiley, Tony Aldave, and Jim Mazzo! If you missed ASCRS or want to know more about Avellino, visit our ASCRS youtube playlist at: http://bit.ly/2WUqp8X Together, our leading experts bring decades of innovative thinking to our effort to bring positive disruption to the treatment of genetic eye diseases. #genetictesting #precisionmedicine #cornea #LASIK

At OIS @ASCRS 2019, our chief sales and marketing officer, Eric Bernabei , shared new insights on the future of gene therapy and genetic eye disease diagnostics Did you miss his remarks on the pioneering advances coming to personalized precision medicine? View and share Eric's exciting presentation. View and share Eric's presentation http://bit.ly/2ZxRZ8Q #positivedisruption #precisionmedicine #genetictesting #ASCRS2019

When a patient presents with corneal opacities, it may indicate one of several different etiologies including genetic corneal dystrophy. Differential diagnosis can often be challenging when clinicians are guided solely by symptomology. Dr. Anthony Aldave is a corneal genetics expert with extensive experience with this challenge. Hear Dr. Aldave discuss the important role genetic testing can play in the clinical evaluation of patients with suspected corneal dystrophy. Watc...h Dr. Aldave's discussion here: http://bit.ly/2KUxbUP #genetictesting #ASCRS2019 #cornea

A new generation of proactive, predictive testing is poised to reshape the treatment of genetic diseases. Hear why Jim Mazzo the newest member of the Avellino board of directors is so excited about the transformative advances that are on their way. Follow @Avellino for the latest in our efforts to bring positive disruption to precision medicine and genetic testing. https://www.youtube.com/watch?v=Vr-SCpVsUpA&feature=youtu.be... #positivedisruption #precisionmedicine #genetictesting

More and more clinical leaders are showing their support and investment in our effort to pioneer genetic testing and gene editing technology. Hear our chief sales and marketing officer, Eric Bernabei, tell Eyewire News about exciting new developments in our steering and advisory teams. Positive disruption is coming to precision medicine and genetic testing. Follow Avellino to see it happen. #positivedisruption #precisionmedicine #genetictesting

We're proud to announce the addition of William F. Stasior to the company’s Executive Advisory Committee. Stasior will act as a consultant to evolve our genetic data infrastructure and artificial intelligence applications, the foundation that will accelerate our expansion in precision medicine. Delivering on the potential of genetic data to address a broad array of health issues is an exciting opportunity, said Stasior. Avellino Labs has built a foundation for genetic diagnosis and therapeutics in ophthalmology and, with a strong data platform, we can rapidly expand the company’s capabilities into other areas of disease research and healthcare. Read the entire story here:https://www.businesswire.com//Prominent-Technologist-Willi